FACULTY AFFILIATIONS AND FINANCIAL DISCLOSURES

Postgraduate Institute for Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. The presenting faculty reported the following:

	Mark G Kris, MD Chief, Thoracic Oncology Service Memorial Sloan-Kettering Cancer Center New York, New York Grants/Research Support: AstraZeneca Pharmaceuticals LP, Telik Inc Consultant: Amgen Inc, Aventis Pharmaceuticals Inc, Genentech BioOncology
	Leslie B Tyson, MS, APN-BC, OCN Nurse Practitioner, Thoracic Oncology Service Memorial Sloan-Kettering Cancer Center New York, New York No financial interests or affiliations to disclose
	Ann Culkin, RN, OCN Clinical Nurse Memorial Sloan-Kettering Cancer Center New York, New York Consultant: Eli Lilly and Company

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. The Postgraduate Institute for Medicine (PIM), Research To Practice and AstraZeneca Pharmaceuticals LP do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Research To Practice and AstraZeneca Pharmaceuticals LP. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.